...
首页> 外文期刊>Journal of Liquid Chromatography & Related Technologies >A LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY METHOD FOR THE SIMULTANEOUS DETERMINATION OF CAPECITABINE, 5′-DEOXY-5-FLUOROCYTIDINE, 5′-DEOXY-5-FLUOROURIDINE, 5-FLUOROURACIL, AND 5-FLUORODIHYDROURACIL IN HUMAN PLASMA
【24h】

A LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY METHOD FOR THE SIMULTANEOUS DETERMINATION OF CAPECITABINE, 5′-DEOXY-5-FLUOROCYTIDINE, 5′-DEOXY-5-FLUOROURIDINE, 5-FLUOROURACIL, AND 5-FLUORODIHYDROURACIL IN HUMAN PLASMA

机译:液相色谱-质谱法同时测定人血浆中的卡西他滨,5′-DEOXY-5-Fluorocydine,5′-DEOXY-5-Fluorouridine,5-氟尿嘧啶和5-氟二氢尿嘧啶

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The objective of the present study was to develop a selective and sensitive liquid chromatography-mass spectrometry (LC-MS) method for the simultaneous quantitation of capecitabine, 5′-deoxy-5-fluorocytidine (5′-DFCR), 5′-deoxy-5-fluorouridine (5′-DFUR), 5-fluorouracil (5-FU), and 5-fluorodihydrouracil (5-FUH2) in human plasma. Chromatography was performed on an Atlantis dC18 column with a mobile phase consisting of 1% formic acid in acetonitrile and 1% formic acid in water gradient elution. 5-fluorocytosine (5-FC) was used as internal standard. LC-MS data were acquired in SIM mode at m/z 130 for 5-FC, m/z 131 for 5-FU, m/z 133 for 5-FUH2, m/z 246 for 5′-DFCR, m/z 247 for 5′-DFUR, and m/z 360 for capecitabine. The drug/internal standard peak area ratios were linked via quadratic relationships to concentrations (100-10000 μg/L for 5-FU; 50-10000 μg/L for 5-FUH2; and 25-10000 μg/L for 5′-DFCR, 5′-DFUR, and capecitabine). The analysis of blank matrices from different donors showed the absence of interfering endogenous components at the retention times of the analytes. No evidence of matrix effect was observed. The method was precise (precision, 0.2-8.3%) and accurate (recovery, 99-104%). Mean extraction efficiencies 89% for each analyte were obtained. The lower limits of quantitation were 25 μg/L for capecitabine, 5′-DFCR, and 5′-DFUR; 50 μg/L for 5-FUH2; and 100 μg/L for 5-FU. This method was successfully used to investigate plasma concentrations of capecitabine and its metabolites in a pharmacokinetic study carried out in patients with metastatic solid tumors receiving oral administration of capecitabine (1600 to 3420 mg according to the patient) twice a day.View full textDownload full textKeywords5′-deoxy-5-fluorocytidine, 5′-deoxy-5-fluorouridine, 5-fluorodihydrouracil, 5-fluorouracil, capecitabine, LC-ESI-MS quantitationRelated var addthis_config = { ui_cobrand: "Taylor & Francis Online", services_compact: "citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,more", pubid: "ra-4dff56cd6bb1830b" }; Add to shortlist Link Permalink http://dx.doi.org/10.1080/10826076.2010.503842
机译:本研究的目的是开发一种选择性和灵敏的液相色谱-质谱(LC-MS)方法,用于同时定量卡培他滨,5€-脱氧-5-氟胞苷(5€-DFCR),5€人血浆中的2-deoxy-5-fluorouridine(5â€-DFUR),5-氟尿嘧啶(5-FU)和5-氟二氢尿嘧啶(5-FUH 2 )。色谱在Atlantis dC18色谱柱上进行,流动相由含1%甲酸的乙腈和1%甲酸的水梯度洗脱组成。 5-氟胞嘧啶(5-FC)用作内标。 LC-MS数据以SIM模式在5-FC的m / z 130,对于5-FU的m / z 131,对于5-FUH 2 的m / z 133,对于m / z 246的m / z 133下采集5€-DFCR,m / z 247代表5€-DFUR和m / z 360代表卡培他滨。药物/内部标准峰面积比通过二次关系链接到浓度(5-FU为100-10000μg/ L; 5-FUH 2 为50-10000μg/ L; 25-10000为25-10000 5 / -DFCR,5 DF-DFUR和卡培他滨微克/升)。来自不同供体的空白基质的分析表明,在分析物的保留时间不存在干扰性内源性成分。没有观察到基质效应的证据。该方法是精确的(精度为0.2-8.3%)和准确的(回收率为99-104%)。每种分析物的平均提取效率均> 89%。定量的下限为卡培他滨,5 --DFCR和5 --DFUR 25微克/升; 5-FUH 2; 为50μg/ L,5-FU为100μg/ L。在每天两次口服卡培他滨(根据患者的不同剂量为1600至3420 mg)的转移性实体瘤患者进行的药代动力学研究中,该方法已成功用于调查卡培他滨及其代谢产物的血浆浓度。查看全文下载全文关键词€2-脱氧-5-氟胞嘧啶核苷,5'-脱氧-5-氟尿苷,5-氟二氢尿嘧啶,5-氟尿嘧啶,卡培他滨,LC-ESI-MS定量“ citeulike,netvibes,twitter,technorati,美味,linkedin,facebook,stumbleupon,digg,google,更多”,发布:“ ra-4dff56cd6bb1830b”};添加到候选列表链接永久链接http://dx.doi.org/10.1080/10826076.2010.503842

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号